EPCAM and cancer: However, only the EpCAM+ population was considered in the cancer cell subset which may not necessarily represent most EOC cells [50], and the degree of immune infiltration of the EOC samples was not included in the analysis, potentially resulting in an overestimated HLA expression in highly infiltrated tumors.